Literature DB >> 15674207

Reflux, dysphagia, and gas bloat after laparoscopic fundoplication in patients with incidentally discovered hiatal hernia and in a control group.

Frederic Triponez1, Jean-Marc Dumonceau, Dan Azagury, Francesco Volonte, Karem Slim, Bernadette Mermillod, Olivier Huber, Philippe Morel.   

Abstract

BACKGROUND: Laparoscopic fundoplication effectively controls reflux symptoms in patients with gastroesophageal reflux disease (GERD). However, symptom relapse and side effects, including dysphagia and gas bloat, may develop after surgery. The aim of the study was to assess these symptoms in patients who underwent laparoscopic fundoplication, as well as in control subjects and patients with hiatal hernia.
METHODS: A standardized, validated questionnaire on reflux, dysphagia, and gas bloat was filled out by 115 patients with a follow-up of 1 to 7 years after laparoscopic fundoplication, as well as by 105 subjects with an incidentally discovered hiatal hernia and 238 control subjects.
RESULTS: Patients who underwent fundoplication had better reflux scores than patients with hiatal hernia ( P = .0001) and similar scores to control subjects ( P = .11). They also had significantly more dysphagia and gas bloat than patients with hiatal hernia and controls ( P < .005 for all comparisons). Gas bloat and dysphagia were more severe in hiatal hernia patients than in controls ( P < 0.005). After fundoplication, the 25% of the patients with the shortest follow-up (1.5 +/- 0.2 years) and the 25% patients with the longest follow-up (5.8 +/- 0.6 years) had similar reflux, dysphagia, and gas bloat scores ( P = .43, .82, and .85, respectively).
CONCLUSION: In patients with severe GERD, laparoscopic fundoplication decreases reflux symptoms to levels found in control subjects. These results appear to be stable over time. However, patients who underwent fundoplication experience more dysphagia and gas bloat than controls and patients with hiatal hernia-symptoms that should be seen as a side effect of the procedure and of GERD itself.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15674207     DOI: 10.1016/j.surg.2004.07.016

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  8 in total

Review 1.  Guidelines for surgical treatment of gastroesophageal reflux disease.

Authors:  Dimitrios Stefanidis; William W Hope; Geoffrey P Kohn; Patrick R Reardon; William S Richardson; Robert D Fanelli
Journal:  Surg Endosc       Date:  2010-08-20       Impact factor: 4.584

2.  Outcome following management of dysphagia after laparoscopic anti-reflux surgery.

Authors:  Huiqi Yang; Cindy Meun; Xiangyu Sun; David I Watson
Journal:  World J Surg       Date:  2012-04       Impact factor: 3.352

3.  Surgeons' experience with laparoscopic fundoplication after the early personal experience: does it have an impact on the outcome?

Authors:  P Salminen; H Hiekkanen; S Laine; J Ovaska
Journal:  Surg Endosc       Date:  2007-02-07       Impact factor: 4.584

4.  Reoperative antireflux surgery for dysphagia.

Authors:  András Légner; Kazuto Tsuboi; Lokesh Bathla; Tommy Lee; Lee E Morrow; Sumeet K Mittal
Journal:  Surg Endosc       Date:  2010-11-05       Impact factor: 4.584

5.  Management of esophageal symptoms following fundoplication.

Authors:  Gregory S Sayuk; Ray E Clouse
Journal:  Curr Treat Options Gastroenterol       Date:  2005-08

6.  Dysphagia and gastroesophageal junction resistance to flow following partial and total fundoplication.

Authors:  Jennifer C Myers; Glyn G Jamieson; Thomas Sullivan; John Dent
Journal:  J Gastrointest Surg       Date:  2011-09-13       Impact factor: 3.452

7.  Laparoscopic repair of paraesophageal hernia with anterior gastropexy: a multicenter study.

Authors:  Christopher R Daigle; Peter Funch-Jensen; Dan Calatayud; Peter Rask; Bo Jacobsen; Teodor P Grantcharov
Journal:  Surg Endosc       Date:  2014-10-08       Impact factor: 4.584

8.  Wrap choice during fundoplication.

Authors:  Simon R Bramhall; Moustafa M Mourad
Journal:  World J Gastroenterol       Date:  2019-12-28       Impact factor: 5.742

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.